Canopy Growth (CGC) Non-Current Debt (2017 - 2025)
Canopy Growth's (CGC) quarterly Non-Current Debt came in at $161.3 million in Q4 2025, down 48.59% year-on-year from $313.8 million in Q4 2024, and down 1.9% quarter-over-quarter from $164.5 million in Q3 2025.
Canopy Growth (CGC) Non-Current Debt (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Non-Current Debt across 9 years of filings, most recently posting $161.3 million for Q4 2025.
- Non-Current Debt for Q4 2025 came in at $161.3 million, down 48.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $161.3 million (down 48.59% YoY), and the FY2025 annual result was $211.9 million, down 42.11% from the prior year.
- Non-Current Debt came in at $161.3 million for Q4 2025 at Canopy Growth, down from $164.5 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $1.3 billion in Q2 2021 to a low of $161.3 million in Q4 2025.
- The 5-year median for Non-Current Debt is $511.7 million (2022), against an average of $627.1 million.
- Across the five-year window, Non-Current Debt jumped 271.11% in 2021 and slumped 53.4% in 2022, its largest moves.
- Canopy Growth's Non-Current Debt stood at $1.2 billion in 2021, then plunged by 53.4% to $552.6 million in 2022, then slumped by 30.78% to $382.5 million in 2023, then decreased by 17.95% to $313.8 million in 2024, then sank by 48.59% to $161.3 million in 2025.
- The last three Non-Current Debt figures came in at $161.3 million (Q4 2025), $164.5 million (Q3 2025), and $208.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 161.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 161.34 Mn |
| Dec 31, 2025 | 161.34 Mn |
| Sep 30, 2025 | 164.46 Mn |
| Sep 30, 2025 | 164.46 Mn |
| Jun 30, 2025 | 208.57 Mn |
| Jun 30, 2025 | 208.57 Mn |
| Mar 31, 2025 | 211.91 Mn |
| Mar 31, 2025 | 211.91 Mn |
| Dec 31, 2024 | 313.83 Mn |
| Dec 31, 2024 | 313.83 Mn |
| Sep 30, 2024 | 304.90 Mn |
| Sep 30, 2024 | 304.90 Mn |
| Jun 30, 2024 | 408.33 Mn |
| Jun 30, 2024 | 408.33 Mn |
| Mar 31, 2024 | 366.08 Mn |
| Mar 31, 2024 | 366.08 Mn |
| Dec 31, 2023 | 382.50 Mn |
| Dec 31, 2023 | 382.50 Mn |
| Sep 30, 2023 | 470.85 Mn |
| Sep 30, 2023 | 470.85 Mn |